1 We aimed to (
1) validate the combined use of visual rati
2 We aimed to: (
1) assess the prevalence of PAD in COPD co
3 We aimed to achieve alpha-synuclein levels sufficient to
4 We aim to address priority epidemiological gaps highligh
5 We aimed to analyse the associations of definitions with
6 We aimed to analyse the effects of the 2010 Deepwater Ho
7 We aimed to analyse the efficacy and safety of clemastin
8 We aimed to analyse trends in mortality in the USA betwe
9 In this study,
we aimed to assess 8-week treatment with ombitasvir, par
10 We aimed to assess changes in molecular signatures of in
11 We aimed to assess colposcopy referral and CIN2+ detecti
12 We aimed to assess CPC's effects on mitochondrial toxici
13 In this study (ASPIRE),
we aimed to assess eltrombopag, an oral thrombopoietin r
14 We aimed to assess glycaemic outcomes when switching fro
15 We aimed to assess molecular differences in the nucleus
16 We aimed to assess mortality by occupation in the UK, di
17 We aimed to assess the activity and safety of dabrafenib
18 We aimed to assess the benefit of MDT in a randomized ph
19 We aimed to assess the benefits of LDL-C lowering on car
20 We aimed to assess the effect of an intensified dosing s
21 We aimed to assess the effect of implementing a comprehe
22 We aimed to assess the effects of an eight-session suppo
23 We aimed to assess the efficacy and safety of ceftazidim
24 We aimed to assess the efficacy and safety of idelalisib
25 We aimed to assess the efficacy and safety of long-actin
26 We aimed to assess the efficacy and safety of pacritinib
27 We aimed to assess the efficacy and safety of regorafeni
28 We aimed to assess the efficacy and safety of sirukumab
29 We aimed to assess the electrophysiological properties o
30 We aimed to assess the impact of a 70-gene signature (70
31 We aimed to assess the in vivo function of CYP2A13 and C
32 We aimed to assess the long-term safety and efficacy of
33 We aimed to assess the persistence of bactericidal antib
34 Herein,
we aimed to assess the potential role of protein-modifyi
35 We aimed to assess the presence of CMV DNA in the blood
36 We aimed to assess the prognostic and predictive value o
37 edictors of inflammation in diverse settings.
We aimed to assess the relation between inflammation (CR
38 r ejection fraction have Vmax in this range,
we aimed to assess the relationship between Vmax and mor
39 We aimed to assess the risk of developing diabetes melli
40 We aimed to assess the risk of Sabin 2 transmission afte
41 In this phase 2 study,
we aimed to assess the safety and activity of two doses
42 Therefore,
we aimed to assess the safety and efficacy of ozanezumab
43 We aimed to assess the safety, tolerability, pharmacokin
44 We aimed to assess the scale of this problem and whether
45 We aimed to assess the use of ATS and the perceived barr
46 We aimed to assess the validity of the previous symptom-
47 We aimed to assess what proportion of variants associate
48 We aimed to assess whether a patient-specific molecular
49 We aimed to assess whether bihormonal bionic pancreas in
50 We aimed to assess whether custirsen in combination with
51 We aimed to assess whether high eosinophil concentration
52 We aimed to assess whether implementation of VISHRAM was
53 We aimed to assess whether provision of mindfulness cour
54 We aimed to assess whether short message service (SMS) r
55 We aimed to assess whether the MC4R genotype affected lo
56 We aimed to build on this research by exploring the rela
57 We aimed to characterize early changes in bone functiona
58 We aimed to characterize the airway microbiota in patien
59 We aimed to characterize the biologic activity of ATIs i
60 We aimed to characterize the vascular effects of a mixed
61 Therefore,
we aimed to characterize this subgroup of patients and t
62 We aimed to clarify it, performing the first meta-analys
63 We aimed to clarify the underlying molecular mechanisms
64 We aimed to compare 5-year outcomes of adolescent surgic
65 We aimed to compare clinical characteristics and outcome
66 We aimed to compare clinical outcomes between ICD patien
67 We aimed to compare endoscopic and clinical outcomes in
68 We aimed to compare frequencies of skin homing (CLA(+) )
69 We aimed to compare in-hospital outcomes of patients wit
70 We aimed to compare oral hygiene habits, orodental statu
71 We aimed to compare the post-booster antibody response i
72 We aimed to compare the response to shading intensity of
73 We aimed to compare the safety and efficacy of intensive
74 Purpose
We aimed to compare treatment effect sizes between overa
75 We aimed to comprehensively describe the treatment casca
76 We aimed to confirm these findings in patients with a BR
77 We aimed to create consensus criteria for clinical and b
78 We aimed to define an association between mtDNA and fibr
79 We aimed to define long-term outcomes and explore risk s
80 ons while exhibiting milder cell loss in PD,
we aimed to define the electrophysiological properties o
81 In this study,
we aimed to define the mechanisms by which noninflammato
82 We aimed to define the proteome contained in mast cell r
83 biology and molecular dynamics simulations,
we aimed to define the underlying mechanism(s) by which
84 We aimed to define whether FMT using a rationally derive
85 r than previously considered.In this review,
we aim to describe recent advances in neuropathology of
86 We aimed to describe a large cohort of mismatch repair (
87 We aimed to describe the epidemiological characteristics
88 We aimed to describe the longer-term health status of se
89 ow, there are five components available, and
we aimed to detect the sensitivity and specificity of rA
90 We aimed to determine apixaban pharmacokinetics at stead
91 We aimed to determine how often S aureus is transmitted
92 We aimed to determine if associations between maternal b
93 We aimed to determine pretreatment pathological tumor ex
94 We aimed to determine the association of influenza and r
95 We aimed to determine the cumulative incidence of/risk f
96 -controlled, within-subject crossover design
we aimed to determine the effect of a single dose of nal
97 We aimed to determine the effect of indoor classroom NO2
98 We aimed to determine the impact of demographic changes
99 Here,
we aimed to determine the importance of elevated circula
100 In the current study,
we aimed to determine the in vivo role of versican in me
101 Here,
we aimed to determine the mechanism of MSC recruitment b
102 We aimed to determine the optimal duration for stents in
103 We aimed to determine the risk of alopecia areata (AA) a
104 In this study,
we aimed to determine the role of GPBAR1 in mediating le
105 From the current published literature,
we aimed to determine the strength of evidence for omali
106 We aimed to determine the temporal trend behind the rise
107 Thus,
we aimed to determine the therapeutic effects of prolong
108 We aimed to determine whether alcohol is required for ef
109 We aimed to determine whether angiotensin (Ang) II cause
110 We aimed to determine whether ART initiation during acut
111 We aimed to determine whether changes in the serum level
112 We aimed to determine whether DNT improved over time in
113 We aimed to determine whether generation of coagulation
114 We aimed to determine whether higher mortality rates wit
115 We aimed to determine whether levothyroxine provided cli
116 We aimed to determine whether OmpA overproduction was a
117 We aimed to determine whether or not (i) these changes a
118 We aimed to determine whether patterns of hypometabolism
119 We aimed to determine whether prenatal exposure to PCBs
120 We aimed to determine whether radiolabeled NPs could be
121 We aimed to determine whether the prognosis of patients
122 We aim to develop an RGC-targeted intraocular drug deliv
123 We aimed to develop a methodical approach that would yie
124 ation of vaccines against paratyphoid fever,
we aimed to develop the first human challenge model of S
125 Here,
we aimed to directly relate dopamine to learning about v
126 e current electrocatalysts are not adequate,
we aim to discover new catalysts by obtaining a detailed
127 We aimed to elucidate the molecular mechanism of eosinop
128 We aimed to elucidate the origin and hydrological pathwa
129 Here,
we aimed to elucidate the relationship between PNS funct
130 In addition,
we aimed to empower patients but did not do anything to
131 We aimed to enrol four controls for every case not infec
132 We aim to establish a classifier capable of simulating h
133 Here,
we aim to establish a gene signature that can identify m
134 Here,
we aim to establish autophagy, a downstream pathway of m
135 We aimed to establish a patient-specific human induced p
136 We aimed to establish an endpoint capturing clinically r
137 In this study,
we aimed to establish equivalence of CT-P6 to reference
138 We aimed to establish the maximum tolerated dose and est
139 We aimed to establish the relationship between the proce
140 Here
we aimed to establish the risk of incident cardiometabol
141 We aimed to establish whether 52-week referral to an ope
142 We aimed to establish whether or not assisted partner se
143 We aimed to estimate associations between maternal PFAS
144 In this study,
we aimed to estimate health impacts (premature mortaliti
145 We aimed to estimate health-adjusted life expectancy (HA
146 We aimed to estimate HIV prevalence among transwomen in
147 We aimed to estimate hypothetical effects of habits (smo
148 We aimed to estimate the difference in opioid relapse-fr
149 et from a large international collaboration,
we aimed to estimate the global incidence, hospital admi
150 We aimed to estimate the prevalence of cyberbullying and
151 We aimed to estimate the relative contributions of genet
152 BACKROUND:
We aimed to evaluate initial PET/CT features of primary
153 inogen exposure or through immune modulation.
We aimed to evaluate NHL risk associated with total and
154 We aimed to evaluate the ability of cellular immune sign
155 We aimed to evaluate the acceptability and effect on imm
156 We aimed to evaluate the addition of bevacizumab to adju
157 We aimed to evaluate the agreement between a wide range
158 </=40% of ALA can be present as trans forms.
We aimed to evaluate the associations between intake of
159 cially sweetened beverages (ASBs) is unclear.
We aimed to evaluate the associations of ASB and SSB con
160 Consequently,
we aimed to evaluate the effect of carbidopa on (18)F-FD
161 We aimed to evaluate the effect of two versions of the c
162 We aimed to evaluate the effectiveness of an adaptive wo
163 a prominent policy to promote healthy eating.
We aimed to evaluate the effects of 2 interpretive nutri
164 We aimed to evaluate the efficacy of the parenteral (int
165 t of the SCALE Obesity and Prediabetes trial
we aimed to evaluate the proportion of individuals with
166 We aimed to evaluate the reproducibility of various mark
167 We aimed to evaluate various approaches of adjustment fo
168 Second,
we aimed to evaluate whether these data have the potenti
169 We aimed to examine cancer risk in HIV-infected people i
170 We aimed to examine HO-1-mediated autophagy induction in
171 We aimed to examine the clinical outcomes of a bioresorb
172 Therefore,
we aimed to examine the functional connectivity of the s
173 We aimed to examine the time-to-TBI in PD patients in th
174 We aimed to examine whether 3 weeks of intensive speech
175 We aimed to examine whether the most electronegative sub
176 We aimed to explore in which situations it is neverthele
177 We aimed to explore original phase/frequency mapping met
178 m these drugs combined with chemotherapy and
we aimed to explore the activity of cetuximab with chemo
179 We aimed to explore the relationship between progressive
180 In this study,
we aimed to explore the roles of secondary surgical cyto
181 We aim to find the reasons for this discordance.
182 Herein,
we aim to further elucidate the signalling mechanisms in
183 We aimed to further assess mepolizumab in patients with
184 We aimed to gain a better understanding of the factors i
185 We aimed to gain insight into MSB0010853 biodistribution
186 Here,
we aimed to gain insights into the genetic architecture
187 As Alpl-null mice die before weaning,
we aimed to generate mouse models of late-onset HPP with
188 meworks, and demonstrating powerful methods,
we aim to help elevate the geography of synchrony into a
189 In this review,
we aim to highlight what the field has uncovered thus fa
190 d evidence base using a systematic approach,
we aim to identify robust patterns across studies and hi
191 igate the pathophysiology of isolated lungs,
we aimed to identify a therapeutic target to optimize lu
192 We aimed to identify and evaluate risk factors that cont
193 In post hoc analyses,
we aimed to identify associations between small fiber de
194 We aimed to identify cells that form IPMNs and mutations
195 In this study,
we aimed to identify characteristics associated with out
196 We aimed to identify diagnostic criteria for cHP that re
197 We aimed to identify genetic and pathological markers th
198 nd human transcriptomic and genomic studies,
we aimed to identify genetic mechanisms underlying depre
199 We aimed to identify how MGUS and multiple myeloma plasm
200 We aimed to identify if delays in bedside dysphagia scre
201 We aimed to identify key principles of targeted therapy
202 Thus,
we aimed to identify metabolomic profiles associated wit
203 Additionally,
we aimed to identify microbial patterns associated with
204 Here,
we aimed to identify miRNAs that are modulated by glucos
205 We aimed to identify Pb-induced transcriptomic changes i
206 We aimed to identify proteins that regulate ENS differen
207 We aimed to identify the effectiveness of prolonged vers
208 We aimed to identify the existing methodological framewo
209 Therefore,
we aimed to identify the mechanism of selinexor-induced
210 We aimed to identify the pathway that connects the brain
211 We aimed to identify the reasons that endoscopists recom
212 We aimed to identify the role of the enzyme acid sphingo
213 In this study,
we aimed to identify the viral factor(s) that mediate mo
214 ional magnetic resonance imaging (MRI) data,
we aimed to identify these mPFC subareas in histological
215 INTRODUCTION:
We aimed to identify whether acute ischemic stroke patie
216 We aimed to improve human nNOS potency and selectivity a
217 We aim to increase insulin secretion by developing strat
218 We aimed to inhibit cartilage degradation by augmenting
219 We aim to investigate the value of clinical screening in
220 We aimed to investigate effects of personal ozone exposu
221 We aimed to investigate predictors and consequences of p
222 Therefore,
we aimed to investigate the age-specific trends in the i
223 We aimed to investigate the association of dog ownership
224 We aimed to investigate the cardiorespiratory health eff
225 We aimed to investigate the causes of screening failure
226 We aimed to investigate the contribution of chymase to s
227 We aimed to investigate the effect of AVATAR therapy on
228 We aimed to investigate the effect of mental health trai
229 We aimed to investigate the effects of asthma and asthma
230 alafenamide has recently been approved, and
we aimed to investigate the efficacy, safety, and tolera
231 We aimed to investigate the feasibility of non-daily PrE
232 We aimed to investigate the frequency and phenotype of t
233 As a result,
we aimed to investigate the molecular composition and ph
234 We aimed to investigate the outcomes of this algorithm.
235 We aimed to investigate the prognostic role of host anti
236 We aimed to investigate the rate of first viral rebound
237 We aimed to investigate urinary NP and BPA levels in rel
238 We aimed to investigate whether day-and-night hybrid clo
239 In the present study,
we aimed to investigate whether microbial dysbiosis was
240 We aimed to investigate whether people with circumscribe
241 We aimed to investigate whether the harmful effects of a
242 Therefore,
we aimed to investigate whether these early-life exposur
243 We aimed to investigate whether this technique would red
244 We aimed to investigate which retinal layers show atroph
245 In this study,
we aim to leverage complementary information encoded in
246 We aimed to measure and validate differences in plasma c
247 Congestive Heart Failure (INTER-CHF) study,
we aimed to measure mortality at 1 year in patients with
248 We aimed to model pathogenic fibroblast migration in SSc
249 We aimed to more precisely estimate the effects of more
250 Purpose
We aimed to predict individual risk of ischemic heart di
251 We aimed to produce country-level, regional, and global
252 We aimed to profile the microbiota at different stages o
253 We aimed to prospectively assess the risk of advanced fi
254 Accordingly,
we aim to provide a conceptual framework for the complex
255 Here,
we aim to provide an integrated overview of the approach
256 We aimed to provide an understanding of the proinflammat
257 tegies and to determine treatment needs, and
we aimed to provide an updated estimate of global incide
258 We aimed to provide nationally representative data for t
259 We aimed to provide the first comprehensive estimates of
260 We aimed to quantify and compare the potential effects o
261 We aimed to quantify and understand prevalence variation
262 We aimed to quantify changes in projected ranges and thr
263 In this study,
we aimed to quantify the effects of immediate versus def
264 We aimed to quantify the fibrosis stage-specific risk of
265 We aimed to quantify the independent and joint associati
266 We aimed to repeat the MATS survey for invasive meningoc
267 In this paper,
we aimed to report an atypical imaging presentation of C
268 We aimed to report efficacy of the 9vHPV vaccine for up
269 In a cohort of hospitalised HIV patients,
we aimed to report the prevalence of TB-blood-culture po
270 We aimed to resolve this controversy using a combined vo
271 We aim to reveal PM 2.5 mobility between cities in China
272 In this study,
we aimed to reveal the mechanisms underlying the behavio
273 We aimed to study the effects of allele-level matching a
274 We aimed to study the passage of live bacteria through t
275 Thus,
we aimed to study the role of CYP2E1 in promoting liver
276 We aimed to summarize our experience regarding prescribi
277 We aimed to synthesize evidence regarding the effectiven
278 We aimed to systematically evaluate serum levels of tryp
279 We aimed to systematically examine the impacts of heat w
280 We aimed to systematically identify 17 different lipid c
281 We aimed to systematically review the face validity (phe
282 We aimed to test the addition of temsirolimus or dinutux
283 We aimed to test the effectiveness of lockable household
284 We aimed to test the efficacy and safety of graded exerc
285 r growth by a length-for-age z score of 0.63.
We aimed to test the efficacy of eggs introduced early i
286 Here,
we aimed to test the hypothesis that combined inhibition
287 We aimed to test the hypothesis that elevated systolic b
288 In the current study,
we aimed to test whether domestic dog facial expressions
289 Thus,
we aimed to test whether dopaminergic function is altere
290 METHODS AND
We aimed to test whether genetically lowered vitamin D l
291 We aimed to trace the geographic origin of HIV-1 infecti
292 We aimed to uncover genes influencing skin colour in Afr
293 urogenesis models and a transgenic approach,
we aimed to understand the cell-source for new neurons i
294 We aimed to understand the role of endothelial autophagy
295 We aimed to understand this mechanism, and how it may co
296 he pathogenesis of CVB3-induced myocarditis,
we aimed to unravel the role of NOD2 in CVB3-induced myo
297 We aimed to use biostatistical modelling to describe the
298 In this study,
we aimed to use microRNAs (miRNAs) - which are critical
299 We aimed to use molecular genotyping to assess antimalar
300 In this study,
we aimed to validate the association of 8 reported signi